A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive ...
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
The Department of Health (DOH) on Friday provided free cervical and breast cancer screening to public school teachers of ...